Anti-ribosomal P protein: A novel antibody in autoimmune hepatitis

Liver International

Volumn 33, Issue 6, 2013, Pages 909-913

  Calich, Ana L ^a   Viana, Vilma S T ^a   Cancado, Eduardo ^a   Tustumi, Francisco ^a   Terrabuio, Débora R B ^a   Leon, Elaine P ^a   Silva, Clovis A ^a   Borba, Eduardo F ^a   Bonfa, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti ribosomal P protein antibody; Autoantibodies; Autoimmune hepatitis; Prognosis; Systemic lupus erythematosus

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BILIRUBIN; GLOBULIN; IMMUNOGLOBULIN G ANTIBODY; RIBOSOME PROTEIN P ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RIBOSOMAL PROTEINS; YOUNG ADULT;

EID: 84878913105     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12155     Document Type: Article

References (35)

1. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
2. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
3. Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 2003; 37: 315-29.
4. Vergani D, Alvarez F, Bianchi FB, et al.; International Autoimmune Hepatitis Group. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677-83.
5. Hirschfield GM. Autoimmune hepatitis - learning about your patients from their autoantibody profiles. Liver Int 2012; 32: 5-7.
6. Montano-Loza AJ, Shums Z, Norman GL, Czaja AJ. Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis. Liver Int 2012; 32: 85-92.
7. Elkon K, Bonfa E, Skelly S, Weissbach H, Brot N. Ribosomal protein autoantibodies in systemic lupus erythematosus. Bioessays 1987; 7: 258-61.
8. Kiss E, Shoenfeld Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus? Clin Rev Allergy Immunol 2007; 32: 37-46.
9. Elkon KB, Bonfa E, Brot N. Antiribosomal antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 377-90.
10. Bonfa E, Elkon KB. Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum 1986; 29: 981-5.
11. Quintana G, Coral-Alvarado P, Aroca G, et al. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus. Autoimmun Rev 2010; 9: 750-5.
12. Hulsey M, Goldstein R, Scully L, Surbeck W, Reichlin M. Anti-ribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol 1995; 74: 252-6.
13. Toubi E, Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 2007; 6: 119-25.
14. Koscec M, Koren E, Wolfson-Reichlin M, et al. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol 1997; 159: 2033-41.
15. Kaw R, Gota C, Bennett A, Barnes D, Calabrese L. Lupus-related hepatitis:complication of lupus or autoimmune association? Case report and review of the literature. Dig Dis Sci 2006; 51: 813-8.
16. Ohira H, Takiguchi J, Rai T, et al. High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis. Hepatol Res 2004; 28: 137-9.
17. Sato T, Uchiumi T, Ozawa T, et al. Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 1991; 18: 1681-4.
18. Mahler M. Sm peptides in differentiation of autoimmune diseases. Adv Clin Chem 2011; 54: 109-28.
19. Smeenk RJ, van den Brink HG, Brinkman K, et al. Anti-dsDNA: choice of assay in relation to clinical value. Rheumatol Int 1991; 11: 101-7.
20. Cançado EL, Vilas-Boas LS, Abrantes-Lemos CP, et al. Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture. Hepatology 1996; 23: 1098-104.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
22. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-33.
23. Doria A, Zen M, Canova M, et al. SLE diagnosis and treatment: when early is early. Autoimmun Rev 2010; 10: 55-60.
24. Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G. DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. J Autoimmun 1999; 13: 111-9.
25. Mahler M, Kessenbrock K, Szmyrka M, et al. International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 2006; 13: 77-83.
26. Agmon-Levin N, Gilburd B, Kivity S, et al. Anti-ribosomal-P antibodies in lupus patients and healthy controls: evaluation of three ELISA assays. Isr Med Assoc J 2009; 11: 403-6.
27. Ghirardello A, Caponi L, Franceschini F, et al. Diagnostic tests for antiribosomal p protein antibodies: a comparative evaluation of immunoblotting and ELISA assays. J Autoimmun 2002; 19: 71-7.
28. Bonfa E, Golombek SJ, Kaufman LD, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265-71.
29. do Nascimento AP, Viana Vdos S, Testagrossa Lde A, et al. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 2006; 54: 1568-72.
30. Massardo L, Burgos P, Martínez ME, et al. Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus 2002; 11: 379-83.
31. Koren E, Schnitz W, Reichlin M. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1325-8.
32. Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992; 89: 1236-41.
33. Nagai T, Arinuma Y, Yanagida T, Yamamoto K, Hirohata S. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum 2005; 52: 847-55.
34. Nagai T, Yanagida T, Hirohata S. Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes. Mod Rheumatol 2011; 21: 57-62.
35. Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011; 25: 653-64.